Pulse Biosciences, Inc. (PLSE)
USD 15.9
(2.19%)
USD 15.9
(2.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -33.04 Million | -47.01 Million | -54.09 Million | -35.36 Million | -34.18 Million | -23.89 Million |
| Net Income | -42.21 Million | -58.5 Million | -63.66 Million | -49.85 Million | -46.97 Million | -37.54 Million |
| Depreciation & Amortization | 1.2 Million | 1.35 Million | 1.14 Million | 1.09 Million | 1.16 Million | 1.31 Million |
| Deferred income taxes | -263 Thousand | - | - | - | - | 28 Thousand |
| Stock-based compensation | 7.18 Million | 5.19 Million | 14.6 Million | 10.07 Million | 11.28 Million | 12.33 Million |
| Change in working capital | 768 Thousand | -3.71 Million | -6.19 Million | 3.2 Million | 860 Thousand | 113 Thousand |
| Other non-cash items | 276 Thousand | 8.66 Million | 13 Thousand | 116 Thousand | -521 Thousand | -112 Thousand |
| Investing Cash Flow | -121 Thousand | -401 Thousand | 7.56 Million | 10.04 Million | -10.1 Million | 26.11 Million |
| Investments in PPE | -121 Thousand | -401 Thousand | -437 Thousand | -441 Thousand | -608 Thousand | -276 Thousand |
| Acquisitions | - | - | - | -10.48 Million | 9.49 Million | - |
| Investment purchases | - | - | - | -29.02 Million | -77.99 Million | -40.29 Million |
| Sales/Maturities of investments | - | - | 8 Million | 39.51 Million | 68.5 Million | 66.69 Million |
| Other Investing Activities | - | - | 8 Million | 10.48 Million | -9.49 Million | 26.39 Million |
| Financing Cash Flow | 16.38 Million | 79.93 Million | 62.68 Million | 30.88 Million | 82 Thousand | 45.49 Million |
| Debt repayment | - | -64.56 Million | -1.53 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 395 Thousand | 486 Thousand | 810 Thousand | 490 Thousand | -613 Thousand | -115 Thousand |
| Common Stock Issuance | 16.39 Million | 15.37 Million | 56.69 Million | 30.88 Million | 695 Thousand | 45.61 Million |
| Other Financing Activities | -6000.00 | -437 Thousand | 7.52 Million | 30.88 Million | 695 Thousand | 45.61 Million |
| Accounts receivables | 109 Thousand | 61 Thousand | -61 Thousand | - | - | - |
| Accounts payables | 263 Thousand | -1.3 Million | 1.16 Million | -266 Thousand | 646 Thousand | 490 Thousand |
| Inventory | - | -2.65 Million | -5.82 Million | - | - | - |
| Other working capital | 396 Thousand | 180 Thousand | -1.47 Million | 3.46 Million | 214 Thousand | -377 Thousand |
| Cash at beginning of period | 61.13 Million | 28.61 Million | 12.46 Million | 6.89 Million | 51.1 Million | 3.38 Million |
| Cash at end of period | 44.36 Million | 61.13 Million | 28.61 Million | 12.46 Million | 6.89 Million | 51.1 Million |
| Capital Expenditure | -121 Thousand | -401 Thousand | -437 Thousand | -441 Thousand | -608 Thousand | -276 Thousand |
| Effect of forex changes on cash | -1.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -16.77 Million | 32.52 Million | 16.15 Million | 5.56 Million | -44.2 Million | 47.71 Million |
| Free Cash Flow | -33.16 Million | -47.41 Million | -54.53 Million | -35.8 Million | -34.79 Million | -24.17 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.68 Million | -11.38 Million | -10.13 Million | -11.93 Million | -42.21 Million | -10.56 Million |
| Depreciation & Amortization | 326 Thousand | 266 Thousand | 299 Thousand | 304 Thousand | 1.2 Million | 299 Thousand |
| Deferred income taxes | - | - | - | -3.52 Million | -263 Thousand | -2.73 Million |
| Stock-based compensation | 2.98 Million | 2.05 Million | 1.75 Million | 3.34 Million | 7.18 Million | 1.79 Million |
| Change in working capital | 1.06 Million | 638 Thousand | -1.7 Million | 1.49 Million | 768 Thousand | -2.01 Million |
| Other non-cash items | -715 Thousand | 2.76 Million | 2.48 Million | 3.53 Million | 276 Thousand | 2.73 Million |
| Investing Cash Flow | -38 Thousand | -29 Thousand | -5000.00 | -43 Thousand | -121 Thousand | -23 Thousand |
| Investments in PPE | -38 Thousand | -29 Thousand | -5000.00 | -43 Thousand | -121 Thousand | -23 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 61.89 Million | -265 Thousand | 305 Thousand | 798 Thousand | 16.38 Million | 2.14 Million |
| Debt repayment | - | - | - | -3.49 Million | - | -1.74 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 182 Thousand | - | 296 Thousand | 104 Thousand | 395 Thousand | - |
| Common Stock Issuance | 59.6 Million | -265 Thousand | 305 Thousand | 804 Thousand | 16.39 Million | 405 Thousand |
| Other Financing Activities | 2.1 Million | -265 Thousand | 305 Thousand | -6000.00 | -6000.00 | 3.48 Million |
| Accounts receivables | -3000.00 | 10 Thousand | -7000.00 | -5000.00 | 109 Thousand | 8000.00 |
| Accounts payables | 92 Thousand | -162 Thousand | -124 Thousand | 437 Thousand | 263 Thousand | -386 Thousand |
| Inventory | - | - | - | 114 Thousand | - | -8000.00 |
| Other working capital | 780 Thousand | 790 Thousand | -1.57 Million | 1.05 Million | 396 Thousand | -1.63 Million |
| Cash at beginning of period | 26.19 Million | 34.88 Million | 44.36 Million | 50.38 Million | 61.13 Million | 58.74 Million |
| Cash at end of period | 79.03 Million | 26.19 Million | 34.88 Million | 44.36 Million | 44.36 Million | 50.38 Million |
| Capital Expenditure | -38 Thousand | -29 Thousand | -5000.00 | -43 Thousand | -121 Thousand | -23 Thousand |
| Effect of forex changes on cash | - | - | - | 2.93 Million | -1.00 | - |
| Net cash flow / Change in cash | 52.83 Million | -8.68 Million | -9.48 Million | -6.02 Million | -16.77 Million | -8.36 Million |
| Free Cash Flow | -9.06 Million | -8.42 Million | -9.78 Million | -6.81 Million | -33.16 Million | -10.51 Million |
NIABY
AGXKF
MSLVF
CBRGU
600563
APRAF